Stock research
AIXC AIxCrypto Holdings, Inc.
Healthcare • Medical - Pharmaceuticals
AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative treatments for both adult and pediatric oncology. Its leading investigational therapeutic,...…
AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative treatments for both adult and pediatric oncology. Its leading investigational therapeutic, QN-302, is a small molecule G-quadruplexes (G4)-selective transcription inhibitor currently progressing through Phase I clinical trials for pancreatic cancer and a range of other solid tumors. The firm is also advancing Pan-RAS, a preclinical-stage program targeting advanced solid tumors. Founded in 1996 and headquartered in Carlsbad, California, the company rebranded from Qualigen Therapeutics, Inc. to AIxCrypto Holdings, Inc. in November 2025.
3M change
-43.33%
Range high
$1.50
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in AIXC?
Price
Showing 3M history. Source: FMP historical price full.
- Prev Close
- $0.77
- Day High
- $0.83
- Day Low
- $0.74
- 52w High
- $8.81
- 52w Low
- $0.62
- Volume
- 6,232.10051
- Avg Volume
- Beta
- 0.487
* TTM/most recent where available
Company
- Ticker
- AIXC
- Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Country
- US
- CEO
- Jiawei Wang
- Employees
- 4
- Website
- www.aixcrypto.ai
Key Metrics
- Market Cap
- 4.21M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).